Evaluated articles

Showing page 1109 of 1181 pages of list content

SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8

This article has 16 authors:
1. Valentina Salvi
2. Hoang Oanh Nguyen
3. Francesca Sozio
4. Tiziana Schioppa
5. Mattia Laffranchi
6. Patrizia Scapini
7. Mauro Passari
8. Ilaria Barbazza
9. Laura Tiberio
10. Nicola Tamassia
11. Cecilia Garlanda
12. Annalisa Del Prete
13. Marco A. Cassatella
14. Alberto Mantovani
15. Silvano Sozzani
16. Daniela Bosisio
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 15, 2021Latest activity Apr 17, 2021
Disparities in excess deaths from the COVID-19 pandemic among migrant workers in Kuwait

This article has 5 authors:
1. Barrak Alahmad
2. Dawoud AlMekhled
3. Ayah Odeh
4. Dalia Albloushi
5. Janvier Gasana
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Sep 14, 2021Latest activity Mar 29, 2021
Substitutions and codon usage in SARS-CoV-2 in mammals indicate natural selection and host adaptation

This article has 9 authors:
1. Zhixiong Lei
2. Dan Zhang
3. Ruiping Yang
4. Jian Li
5. Weixing Du
6. Yanqing Liu
7. Huabing Tan
8. Zhixin Liu
9. Long Liu
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 5, 2021Latest activity Apr 7, 2021
In Vitro Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-2

This article has 5 authors:
1. Svetlana Khaiboullina
2. Timsy Uppal
3. Nikhil Dhabarde
4. Vaidyanathan Ravi Subramanian
5. Subhash C. Verma
Reviewed by ScreenIT

This article has 1 evaluationAppears in 2 listsLatest version Aug 25, 2020Latest activity Mar 1, 2021
Fine-tuning the Spike: Role of the nature and topology of the glycan shield in the structure and dynamics of the SARS-CoV-2 S

This article has 6 authors:
1. Aoife M. Harbison
2. Carl A. Fogarty
3. Toan K. Phung
4. Akash Satheesan
5. Benjamin L. Schulz
6. Elisa Fadda
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 1, 2021Latest activity Apr 3, 2021
Returning to the Workplace During the COVID-19 Pandemic: The Concerns of Australian Workers

This article has 5 authors:
1. Daniel Griffiths
2. Luke Sheehan
3. Caryn van Vreden
4. Peter Whiteford
5. Alex Collie
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 15, 2021Latest activity Apr 2, 2021
Comparison of cough particle exposure for indoor commercial and aircraft cabin spaces

This article has 5 authors:
1. Angela C. Davis
2. Danny J. Menard
3. Andrew D. Clark
4. Joshua J. Cummins
5. Nels A. Olson
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 26, 2021Latest activity Mar 29, 2021
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals

This article has 46 authors:
1. Davide F. Robbiani
2. Christian Gaebler
3. Frauke Muecksch
4. Julio C. C. Lorenzi
5. Zijun Wang
6. Alice Cho
7. Marianna Agudelo
8. Christopher O. Barnes
9. Anna Gazumyan
10. Shlomo Finkin
11. Thomas Hagglof
12. Thiago Y. Oliveira
13. Charlotte Viant
14. Arlene Hurley
15. Hans-Heinrich Hoffmann
16. Katrina G. Millard
17. Rhonda G. Kost
18. Melissa Cipolla
19. Kristie Gordon
20. Filippo Bianchini
21. Spencer T. Chen
22. Victor Ramos
23. Roshni Patel
24. Juan Dizon
25. Irina Shimeliovich
26. Pilar Mendoza
27. Harald Hartweger
28. Lilian Nogueira
29. Maggi Pack
30. Jill Horowitz
31. Fabian Schmidt
32. Yiska Weisblum
33. Eleftherios Michailidis
34. Alison W. Ashbrook
35. Eric Waltari
36. John E. Pak
37. Kathryn E. Huey-Tubman
38. Nicholas Koranda
39. Pauline R. Hoffman
40. Anthony P. West
41. Charles M. Rice
42. Theodora Hatziioannou
43. Pamela J. Bjorkman
44. Paul D. Bieniasz
45. Marina Caskey
46. Michel C. Nussenzweig
Reviewed by ScreenIT

This article has 2 evaluationsAppears in 1 listLatest version May 15, 2020Latest activity Mar 1, 2021
Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States

This article has 14 authors:
1. Kaitlin Rainwater-Lovett
2. John T Redd
3. Miles A Stewart
4. Natalia Elías Calles
5. Tyler Cluff
6. Mike Fang
7. Mark J Panaggio
8. Anastasia S Lambrou
9. Jonathan K Thornhill
10. Christopher Bradburne
11. Samuel Imbriale
12. Jeffrey D Freeman
13. Michael Anderson
14. Robert P Kadlec
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 24, 2021Latest activity Apr 14, 2021
De novo design of ACE2 protein decoys to neutralize SARS-CoV-2

This article has 30 authors:
1. Thomas W. Linsky
2. Renan Vergara
3. Nuria Codina
4. Jorgen W. Nelson
5. Matthew J. Walker
6. Wen Su
7. Tien-Ying Hsiang
8. Katharina Esser-Nobis
9. Kevin Yu
10. Yixuan J. Hou
11. Tanu Priya
12. Masaya Mitsumoto
13. Avery Pong
14. Uland Y. Lau
15. Marsha L. Mason
16. Jerry Chen
17. Alex Chen
18. Tania Berrocal
19. Hong Peng
20. Nicole S. Clairmont
21. Javier Castellanos
22. Yu-Ru Lin
23. Anna Josephson-Day
24. Ralph Baric
25. Carl D. Walkey
26. Ryan Swanson
27. Michael Gale
28. Luis M. Blancas-Mejia
29. Hui-Ling Yen
30. Daniel-Adriano Silva
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 3, 2020Latest activity Mar 1, 2021
Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2

This article has 3 authors:
1. Nicolas Castonguay
2. Wandong Zhang
3. Marc-André Langlois
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 29, 2021Latest activity Mar 15, 2021
High-content screening of coronavirus genes for innate immune suppression reveals enhanced potency of SARS-CoV-2 proteins

This article has 22 authors:
1. Erika J. Olson
2. David M. Brown
3. Timothy Z. Chang
4. Lin Ding
5. Tai L. Ng
6. H. Sloane Weiss
7. Yukiye Koide
8. Peter Koch
9. Nathan Rollins
10. Pia Mach
11. Tobias Meisinger
12. Trenton Bricken
13. Joshua Rollins
14. Yun Zhang
15. Colin Molloy
16. Yun Zhang
17. Bridget N. Queenan
18. Timothy Mitchison
19. Debora Marks
20. Jeffrey C. Way
21. John I. Glass
22. Pamela A. Silver
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 2, 2021Latest activity Mar 15, 2021
Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?

This article has 8 authors:
1. Krzysztof Lukaszuk
2. Jolanta Kiewisz
3. Karolina Rozanska
4. Amira Podolak
5. Grzegorz Jakiel
6. Izabela Woclawek-Potocka
7. Lukasz Rabalski
8. Aron Lukaszuk
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 2, 2021Latest activity May 4, 2021
Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants

This article has 9 authors:
1. Austin N. Spratt
2. Saathvik R. Kannan
3. Lucas T. Woods
4. Gary A. Weisman
5. Thomas P. Quinn
6. Christian L. Lorson
7. Anders Sönnerborg
8. Siddappa N. Byrareddy
9. Kamal Singh
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 24, 2021Latest activity Mar 27, 2021
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents

This article has 11 authors:
1. Thuc Nguyen Dan Do
2. Kim Donckers
3. Laura Vangeel
4. Arnab K. Chatterjee
5. Philippe A. Gallay
6. Michael D. Bobardt
7. John P. Bilello
8. Tomas Cihlar
9. Steven De Jonghe
10. Johan Neyts
11. Dirk Jochmans
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 25, 2021Latest activity Mar 28, 2021
Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp3 Papain-like Protease

This article has 19 authors:
1. Chew Theng Lim
2. Kang Wei Tan
3. Mary Wu
4. Rachel Ulferts
5. Lee A. Armstrong
6. Eiko Ozono
7. Lucy S. Drury
8. Jennifer C. Milligan
9. Theresa U. Zeisner
10. Jingkun Zeng
11. Florian Weissmann
12. Berta Canal
13. Ganka Bineva-Todd
14. Michael Howell
15. Nicola O’Reilly
16. Rupert Beale
17. Yogesh Kulathu
18. Karim Labib
19. John F.X Diffley
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 8, 2021Latest activity Apr 10, 2021
Analysis of accumulated SARS-CoV-2 seroconversion in North Carolina: The COVID-19 Community Research Partnership

This article has 23 authors:
1. John C. Williamson
2. Thomas F. Wierzba
3. Michele Santacatterina
4. Iqra Munawar
5. Austin L. Seals
6. Christine Ann Pittman Ballard
7. Martha Alexander-Miller
8. Michael S. Runyon
9. Lewis H. McCurdy
10. Michael A. Gibbs
11. Amina Ahmed
12. William H. Lagarde
13. Patrick D. Maguire
14. Robin King-Thiele
15. Terri Hamrick
16. Abdalla Ihmeidan
17. Shakira Henderson
18. T. Ryan Gallaher
19. Diane Uschner
20. Sharon L. Edelstein
21. David M. Herrington
22. John W. Sanders
23. on behalf of the North Carolina sites of the COVID-19 Community Research Partnership
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 18, 2022Latest activity Mar 15, 2021
Investigating the first stage of the COVID-19 pandemic in Ukraine using epidemiological and genomic data

This article has 7 authors:
1. Yuriy Gankin
2. Alina Nemira
3. Vladimir Koniukhovskii
4. Gerardo Chowell
5. Thomas A. Weppelmann
6. Pavel Skums
7. Alexander Kirpich
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 1, 2021Latest activity Mar 15, 2021
Large-scale analysis of SARS-CoV-2 synonymous mutations reveals the adaptation to the human codon usage during the virus evolution

This article has 10 authors:
1. Daniele Ramazzotti
2. Fabrizio Angaroni
3. Davide Maspero
4. Mario Mauri
5. Deborah D’Aliberti
6. Diletta Fontana
7. Marco Antoniotti
8. Elena Maria Elli
9. Alex Graudenzi
10. Rocco Piazza
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 23, 2021Latest activity Apr 26, 2021
Targeted Drug Repurposing Against the SARS-CoV-2 E channel Identifies Blockers With in vitro Antiviral Activity

This article has 3 authors:
1. Prabhat Pratap Singh Tomar
2. Miriam Krugliak
3. Isaiah Tuvia Arkin
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Feb 24, 2021Latest activity Mar 1, 2021

Evaluated articles

SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8

Disparities in excess deaths from the COVID-19 pandemic among migrant workers in Kuwait

Substitutions and codon usage in SARS-CoV-2 in mammals indicate natural selection and host adaptation

In Vitro Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-2

Fine-tuning the Spike: Role of the nature and topology of the glycan shield in the structure and dynamics of the SARS-CoV-2 S

Returning to the Workplace During the COVID-19 Pandemic: The Concerns of Australian Workers

Comparison of cough particle exposure for indoor commercial and aircraft cabin spaces

Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals

Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States

De novo design of ACE2 protein decoys to neutralize SARS-CoV-2

Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2

High-content screening of coronavirus genes for innate immune suppression reveals enhanced potency of SARS-CoV-2 proteins

Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?

Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants

A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents

Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp3 Papain-like Protease

Analysis of accumulated SARS-CoV-2 seroconversion in North Carolina: The COVID-19 Community Research Partnership

Investigating the first stage of the COVID-19 pandemic in Ukraine using epidemiological and genomic data

Large-scale analysis of SARS-CoV-2 synonymous mutations reveals the adaptation to the human codon usage during the virus evolution

Targeted Drug Repurposing Against the SARS-CoV-2 E channel Identifies Blockers With in vitro Antiviral Activity